Young nearsighted kids who wear bifocal contact lenses that slow uncoordinated eye growth do not lose the benefits of the treatment once they stop wearing the lenses, new research shows.

Shares in ophthalmology specialist Bausch + Lomb (B+L) have lost almost 10% ... firms had partnered on a potential bid for B+L, which sells contact lenses as well as ophthalmic pharmaceuticals ...

Rarest of all is a rigid gas permeable solution, specifically made for hard contact lenses. This liquid is solely for storing, not cleaning or disinfecting. From top brand Bausch + Lomb comes this ...

If you’re on the fence about investing in Integer Holdings Corporation or Bausch + Lomb Corporation ... provides contact lens that covers the spectrum of wearing modalities, including daily disposable ...

By providing an easy way to recycle contact lenses and their packaging, Bausch + Lomb's programs help prevent waste from piling up in landfills and waterways. As more consumers participate, the impact ...

Bausch + Lomb acquired Whitecap Biosciences, including its two therapies for potential use in glaucoma and geographic atrophy ...

Bausch + Lomb (BLCO) announced the commercial launch of the enVista Aspire monofocal and toric intraocular lenses in the European Union after ...

Character Biosciences announced a collaboration with Bausch + Lomb with an initial focus on developing innovative treatments ...

Bausch + Lomb. "In the U.S., where enVista Aspire is currently available, surgeons and their patients appreciate the features of these monofocal lenses that are designed for a broader depth of ...

Bausch + Lomb moved to bolster the eye-care company's pipeline of clinical-stage offerings with the acquisition of Whitecap Biosciences, a firm developing two therapies for potential use in glaucoma ...